BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 29977454)

  • 21. Identifying hub genes and dysregulated pathways in hepatocellular carcinoma.
    Jin B; Wang W; Du G; Huang GZ; Han LT; Tang ZY; Fan DG; Li J; Zhang SZ
    Eur Rev Med Pharmacol Sci; 2015 Feb; 19(4):592-601. PubMed ID: 25753876
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Identification of significant gene and pathways involved in HBV-related hepatocellular carcinoma by bioinformatics analysis.
    Xie S; Jiang X; Zhang J; Xie S; Hua Y; Wang R; Yang Y
    PeerJ; 2019; 7():e7408. PubMed ID: 31392101
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Identification of 40S ribosomal protein S8 as a novel biomarker for alcohol‑associated hepatocellular carcinoma using weighted gene co‑expression network analysis.
    Bi N; Sun Y; Lei S; Zeng Z; Zhang Y; Sun C; Yu C
    Oncol Rep; 2020 Aug; 44(2):611-627. PubMed ID: 32627011
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Identification of potential hub genes related to the progression and prognosis of hepatocellular carcinoma through integrated bioinformatics analysis.
    Song X; Du R; Gui H; Zhou M; Zhong W; Mao C; Ma J
    Oncol Rep; 2020 Jan; 43(1):133-146. PubMed ID: 31746405
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Screening and identification of key biomarkers in hepatocellular carcinoma: Evidence from bioinformatic analysis.
    Li L; Lei Q; Zhang S; Kong L; Qin B
    Oncol Rep; 2017 Nov; 38(5):2607-2618. PubMed ID: 28901457
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Identification of Potential Key Genes for Hepatitis B Virus-Associated Hepatocellular Carcinoma by Bioinformatics Analysis.
    Chen Z; Chen J; Huang X; Wu Y; Huang K; Xu W; Xie L; Zhang X; Liu H
    J Comput Biol; 2019 May; 26(5):485-494. PubMed ID: 30864827
    [No Abstract]   [Full Text] [Related]  

  • 27. Screening of significant biomarkers with poor prognosis in hepatocellular carcinoma via bioinformatics analysis.
    Sun Q; Liu P; Long B; Zhu Y; Liu T
    Medicine (Baltimore); 2020 Aug; 99(32):e21702. PubMed ID: 32769939
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Screening and Functional Prediction of Key Candidate Genes in Hepatitis B Virus-Associated Hepatocellular Carcinoma.
    Chen X; Liao L; Li Y; Huang H; Huang Q; Deng S
    Biomed Res Int; 2020; 2020():7653506. PubMed ID: 33102593
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Application of Molecular Nanoprobes in the Analysis of Differentially Expressed Genes and Prognostic Models of Primary Hepatocellular Carcinoma.
    Luo S; Gan L; Luo Y; Zhang Z; Li L; Wang H; Li T; Chen Q; Huang Y; He J; Zhong L; Liu X; Wu P; Wang Y; Zhao Y; Zhang Z
    J Biomed Nanotechnol; 2021 Jun; 17(6):1020-1033. PubMed ID: 34167617
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Identification and characterization of sexual dimorphism‑linked gene expression profile in hepatocellular carcinoma.
    Wu Y; Yao N; Feng Y; Tian Z; Yang Y; Zhao Y
    Oncol Rep; 2019 Sep; 42(3):937-952. PubMed ID: 31322260
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The SNHG1-Centered ceRNA Network Regulates Cell Cycle and Is a Potential Prognostic Biomarker for Hepatocellular Carcinoma.
    Zhou L; Zhang Q; Deng H; Ou S; Liang T; Zhou J
    Tohoku J Exp Med; 2022 Nov; 258(4):265-276. PubMed ID: 36244757
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Key signaling pathways, genes and transcription factors associated with hepatocellular carcinoma.
    Wang J; Tian Y; Chen H; Li H; Zheng S
    Mol Med Rep; 2018 Jun; 17(6):8153-8160. PubMed ID: 29658607
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Aberrant expression of cell cycle and material metabolism related genes contributes to hepatocellular carcinoma occurrence.
    Yan H; Li Z; Shen Q; Wang Q; Tian J; Jiang Q; Gao L
    Pathol Res Pract; 2017 Apr; 213(4):316-321. PubMed ID: 28238542
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Identification and interaction analysis of key genes and microRNAs in hepatocellular carcinoma by bioinformatics analysis.
    Mou T; Zhu D; Wei X; Li T; Zheng D; Pu J; Guo Z; Wu Z
    World J Surg Oncol; 2017 Mar; 15(1):63. PubMed ID: 28302149
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Investigation of microRNA expression signatures in HCC via microRNA Gene Chip and bioinformatics analysis.
    Zhou L; Zhu W; Wang G; Cao X; Zhang X; Chen Q
    Pathol Res Pract; 2020 Jun; 216(6):152982. PubMed ID: 32360250
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Microarray Data Mining and Preliminary Bioinformatics Analysis of Hepatitis D Virus-Associated Hepatocellular Carcinoma.
    Yu Z; Ma X; Zhang W; Chang X; An L; Niu M; Chen Y; Sun C; Yang Y
    Biomed Res Int; 2021; 2021():1093702. PubMed ID: 33564675
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Identification of hub genes associated with prognosis, diagnosis, immune infiltration and therapeutic drug in liver cancer by integrated analysis.
    Lei X; Zhang M; Guan B; Chen Q; Dong Z; Wang C
    Hum Genomics; 2021 Jun; 15(1):39. PubMed ID: 34187556
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Bioinformatics analysis of key biomarkers and potential molecular mechanisms in hepatocellular carcinoma induced by hepatitis B virus.
    Li Z; Xu J; Cui H; Song J; Chen J; Wei J
    Medicine (Baltimore); 2020 May; 99(20):e20302. PubMed ID: 32443377
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Identification of Key Pathways and Genes in Anaplastic Thyroid Carcinoma via Integrated Bioinformatics Analysis.
    Hu S; Liao Y; Chen L
    Med Sci Monit; 2018 Sep; 24():6438-6448. PubMed ID: 30213925
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Identification of Potential Gene Network Associated with HCV-Related Hepatocellular Carcinoma Using Microarray Analysis.
    Cheng Y; Ping J; Chen J
    Pathol Oncol Res; 2018 Jul; 24(3):507-514. PubMed ID: 28669080
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.